ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA
· Real-Time Price · USD
4.47
0.03 (0.68%)
At close: Aug 15, 2025, 12:08 PM
ENDRA Life Sciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.06M | 3.23M | 4.75M | 6.4M | 1.13M | 2.83M | 3.33M | 4.82M | 2.36M | 4.89M | 8.02M | 11.28M | 7.13M | 9.46M | 11.79M | 14.04M | 16.84M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 371.4K | 371.4K | 3.11M | 3.36M | 3.36M | 3.26M | 650.6K | 536.05K | 438.33K | 5.99K | 5.99K | 5.99K | 5.99K | 5.99K | 5.99K | 0.00 | 0.00 |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | -305.88K | -506.91K | -428.53K | n/a | -914.26K | -834.86K | -1.06M | -1.35M | -1.18M | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | 2.71M | 2.62M | 2.76M | 2.76M | 2.74M | 2.64M | 2.63M | 2.37M | 1.93M | 1.28M | 1.5M | 1.32M | 726.61K |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | 305.88K | 506.91K | 428.53K | n/a | 914.26K | 834.86K | 1.06M | 1.35M | 1.18M | 5.99K | 5.99K |
Total Current Assets | 2.18M | 3.43M | 4.96M | 6.71M | 1.27M | 3.03M | 6.4M | 8.08M | 5.52M | 8.53M | 11.56M | 14.49M | 10.12M | 12.09M | 14.47M | 16.34M | 18.35M |
Property-Plant & Equipment | 618.99K | 647.29K | 310.05K | 364.06K | 425.19K | 465.87K | 554.27K | 624.72K | 697.43K | 741.47K | 772.07K | 815.8K | 811.68K | 774.54K | 838.09K | 899.59K | 547.38K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 990.39K | 1.02M | 3.42M | 3.73M | 3.79M | 3.72M | 1.2M | 1.16M | 1.14M | 747.46K | 778.05K | 821.78K | 817.66K | 780.53K | 844.07K | 899.59K | 547.38K |
Total Assets | 3.17M | 4.45M | 8.38M | 10.44M | 5.06M | 6.75M | 7.6M | 9.24M | 6.65M | 9.27M | 12.34M | 15.31M | 10.94M | 12.87M | 15.31M | 17.24M | 18.9M |
Account Payables | 223.59K | 269.68K | 279.42K | 300.36K | 521.58K | 360.4K | 419.14K | 414.94K | 524.03K | 613.96K | 636.7K | 785.07K | 833.86K | 791.05K | 747.76K | 807.11K | 447.95K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | -447.63K | -443.42K | n/a | n/a | n/a | n/a | n/a | -791.05K | n/a | n/a | n/a |
Short-Term Debt | n/a | 96.94K | 208.18K | 182.73K | 178.24K | 28.48K | 28.48K | 28.48K | 28.48K | 28.48K | 147.06K | 142.03K | 137.12K | 132.33K | 127.7K | 123.19K | 79.17K |
Other Current Liabilities | n/a | 5.75K | 0.00 | 90.36K | -18.37K | 148.79K | 214.65K | 290.62K | 821.54K | 158.93K | 375.89K | 213.81K | 69.27K | 269.46K | 172.61K | 169.65K | 25.31K |
Total Current Liabilities | 565.78K | 605.23K | 814.04K | 1.35M | 1.22M | 903.1K | 2.17M | 2.03M | 1.83M | 1.7M | 1.71M | 1.5M | 1.36M | 1.54M | 1.58M | 1.64M | 765.83K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 237.16K | n/a | n/a | n/a | 28.48K | 28.48K | 28.48K | 28.48K | 28.48K | 28.48K | 28.48K |
Other Long-Term Liabilities | 390.72K | 799.28K | 910.56K | n/a | n/a | n/a | -237.16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 851.93K | 1.29M | 960.38K | 98.42K | 145.82K | 192.06K | 237.16K | 281.15K | 324.06K | 365.92K | 434.26K | 472.65K | 510.1K | 546.63K | 581.31K | 614.68K | 280.83K |
Total Liabilities | 1.42M | 1.89M | 1.77M | 1.45M | 1.36M | 1.1M | 2.41M | 2.31M | 2.16M | 2.07M | 2.14M | 1.98M | 1.87M | 2.09M | 2.16M | 2.25M | 1.05M |
Total Debt | 587.3K | 584.42K | 237.16K | 281.15K | 324.06K | 394.4K | 434.26K | 472.65K | 510.1K | 546.63K | 581.31K | 614.68K | 647.22K | 678.96K | 709.01K | 737.87K | 360K |
Common Stock | 55.00 | 53.00 | 53.00 | 7.24K | 1.09K | 1.04K | 841.00 | 748.00 | 317.00 | 317.00 | 6.32K | 6.32K | 4.45K | 4.25K | 4.21K | 4.18K | 4.16K |
Retained Earnings | -104.47M | -103.44M | -99.29M | -96.94M | -94.71M | -91.93M | -90.47M | -87.37M | -84.81M | -81.87M | -78.58M | -75.14M | -71.55M | -68.69M | -65.59M | -62.93M | -59.73M |
Comprehensive Income | n/a | n/a | n/a | 27.00 | 301.00 | 5.23K | n/a | n/a | 3.69K | 6.07K | 8.49K | 5.81K | 8.77K | n/a | 42.66K | 74.91K | -617.29K |
Shareholders Equity | 1.75M | 2.56M | 6.6M | 8.99M | 3.7M | 5.66M | 5.2M | 6.93M | 4.5M | 7.2M | 10.2M | 13.33M | 9.07M | 10.78M | 13.16M | 14.99M | 17.85M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |